152 related articles for article (PubMed ID: 29221110)
1. A seven-gene signature predicts overall survival of patients with colorectal cancer.
Chen H; Sun X; Ge W; Qian Y; Bai R; Zheng S
Oncotarget; 2017 Nov; 8(56):95054-95065. PubMed ID: 29221110
[TBL] [Abstract][Full Text] [Related]
2. A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma.
He W; Yan Q; Fu L; Han Y
Oncol Lett; 2019 Aug; 18(2):1381-1387. PubMed ID: 31423201
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of an immune-related gene pairs signature in colorectal cancer.
Wu J; Zhao Y; Zhang J; Wu Q; Wang W
Oncoimmunology; 2019; 8(7):1596715. PubMed ID: 31143520
[TBL] [Abstract][Full Text] [Related]
4. A molecular signature for the prediction of recurrence in colorectal cancer.
Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
[TBL] [Abstract][Full Text] [Related]
5. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
6. Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis.
Bu L; Huang F; Li M; Peng Y; Wang H; Zhang M; Peng L; Liu L; Zhao Q
PeerJ; 2021; 9():e11430. PubMed ID: 34035992
[TBL] [Abstract][Full Text] [Related]
7. Gene signatures of estrogen and progesterone receptor pathways predict the prognosis of colorectal cancer.
Liu D
FEBS J; 2016 Aug; 283(16):3115-33. PubMed ID: 27376509
[TBL] [Abstract][Full Text] [Related]
8. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer.
Zhou Z; Mo S; Dai W; Ying Z; Zhang L; Xiang W; Han L; Wang Z; Li Q; Wang R; Cai G
Front Oncol; 2019; 9():878. PubMed ID: 31552190
[No Abstract] [Full Text] [Related]
10. Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients.
Li J; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Deng Y
Cancer Manag Res; 2020; 12():3301-3310. PubMed ID: 32494194
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
Alajez NM
PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
[TBL] [Abstract][Full Text] [Related]
14. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
15. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer.
Hao JM; Chen JZ; Sui HM; Si-Ma XQ; Li GQ; Liu C; Li JL; Ding YQ; Li JM
J Pathol; 2010 Mar; 220(4):475-89. PubMed ID: 20077526
[TBL] [Abstract][Full Text] [Related]
16. A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients.
Zou YF; Rong YM; Tan YX; Xiao J; Yu ZL; Chen YF; Ke J; Li CH; Chen X; Wu XJ; Lan P; Lin XT; Gao F
Cancer Cell Int; 2019; 19():243. PubMed ID: 31572060
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of ALDH1
Vishnubalaji R; Manikandan M; Fahad M; Hamam R; Alfayez M; Kassem M; Aldahmash A; Alajez NM
Oncotarget; 2018 Mar; 9(17):13551-13564. PubMed ID: 29568377
[TBL] [Abstract][Full Text] [Related]
18. Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer.
Sun X; Wang X; Feng W; Guo H; Tang C; Lu Y; Xiang X; Bao Y
Oncol Lett; 2017 Apr; 13(4):2089-2096. PubMed ID: 28454366
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases.
Yang F; Cai S; Ling L; Zhang H; Tao L; Wang Q
Front Genet; 2020; 11():622659. PubMed ID: 33537062
[TBL] [Abstract][Full Text] [Related]
20. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
